1. Quorum Sensing and NF-κB Inhibition of Synthetic Coumaperine Derivatives from Piper nigrum
- Author
-
Ariel Kushmaro, Jacob Gopas, Yael Kadosh, Yifat Baruch, Karin Yaniv, Rajendran Kumar, and Subramani Muthuraman
- Subjects
plant natural-based compounds ,amide alkaloids ,Pharmaceutical Science ,Virulence ,Inflammation ,Bacterial growth ,Article ,Analytical Chemistry ,Microbiology ,lcsh:QD241-441 ,coumaperine ,03 medical and health sciences ,0302 clinical medicine ,Piperidines ,lcsh:Organic chemistry ,Downregulation and upregulation ,Transcription (biology) ,Drug Discovery ,medicine ,NF-kB ,Physical and Theoretical Chemistry ,030304 developmental biology ,Piper nigrum ,0303 health sciences ,Piper ,biology ,Chemistry ,Organic Chemistry ,NF-kappa B ,quorum sensing ,biology.organism_classification ,Anti-Bacterial Agents ,antibacterial ,Quorum sensing ,Chemistry (miscellaneous) ,030220 oncology & carcinogenesis ,Molecular Medicine ,medicine.symptom ,Antibacterial activity - Abstract
Bacterial communication, termed Quorum Sensing (QS), is a promising target for virulence attenuation and the treatment of bacterial infections. Infections cause inflammation, a process regulated by a number of cellular factors, including the transcription Nuclear Factor kappa B (NF-κB), this factor is found to be upregulated in many inflammatory diseases, including those induced by bacterial infection. In this study, we tested 32 synthetic derivatives of coumaperine (CP), a known natural compound found in pepper (Piper nigrum), for Quorum Sensing Inhibition (QSI) and NF-κB inhibitory activities. Of the compounds tested, seven were found to have high QSI activity, three inhibited bacterial growth and five inhibited NF-κB. In addition, some of the CP compounds were active in more than one test. For example, compounds CP-286, CP-215 and CP-158 were not cytotoxic, inhibited NF-κB activation and QS but did not show antibacterial activity. CP-154 inhibited QS, decreased NF-κB activation and inhibited bacterial growth. Our results indicate that these synthetic molecules may provide a basis for further development of novel therapeutic agents against bacterial infections.
- Published
- 2021
- Full Text
- View/download PDF